Despite the market volatility, shares in Zoono (ASX:ZNO) have been in an uptrend in recent months. The question now for investors is whether that price strength will continue. Finding stocks with the potential to break-out as their pop...
ZNO — Zoono Share Price
0.000.00%
Last trade - 00:00Consumer DefensivesHighly SpeculativeMicro CapNeutral
- AU$34.72m
- AU$30.99m
- NZ$27.15m
- 51
- 57
- 18
- 40
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.99 | ||
| Price to Tang. Book | 2.85 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.03 | ||
| EV to EBITDA | 32.66 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.36% | ||
| Return on Equity | 4.47% | ||
| Operating Margin | 3.25% | ||
Financial Summary
| Year End 30th Jun | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | NZ$m | 0.79 | 2.43 | 1.78 | 38.38 | 27.15 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | -71.51 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
12345678910
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Latest News & Insights for ZNO
Intriguing research into stock market price trends shows that investors behave strangely when a stock trades close to its 52-week high... Despite flying high, holders of the shares are more likely to sell out and snatch a profit than h...
It's a good time to be a shareholder in Zoono (ASX:ZNO): as the share approaches its 52-week high, holders may be wondering whether to sell and take the profit, or buy more and ride the uptrend. Shares in Zoono are currently trading cl...
Profile Summary
Zoono Group Limited is an Australia-based antibacterial technology company. The Company is focused on developing, manufacturing and distributing of scientifically validated antimicrobial solutions. The Company's products are based on the Zoono molecule, which is a water-bases antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mold. The Company's products include sprays, sanitizers, wipes and foams suited for skin care, surface sanitizers, business, and mold remediation treatments. Its sanitizer products include surface sanitizer and hand sanitizer in the form of refill sachets, wall dispenser units, bulk carton, shield surface sanitizers.
Directors
- Last Annual
- June 30th, 2021
- Last Interim
- December 31st, 2021
- Incorporated
- October 8th, 1986
- Public Since
- July 21st, 1988
- No. of Shareholders
- 5,978
- No. of Employees
- 2
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 165,312,707
- Address
- L 12 225 George St, SYDNEY, 2000
- Web
- http://www.goldsearch.com/
- Phone
- +61 280428481
- Auditors
- Hall Chadwick
Upcoming Events for ZNO
Full Year 2022 Zoono Group Ltd Earnings Release
Similar to ZNO
3P Learning
Australian Stock Exchange - SEATS
Advance Zinctek
Australian Stock Exchange - SEATS
AF Legal
Australian Stock Exchange - SEATS
AMA
Australian Stock Exchange - SEATS
Anagenics
Australian Stock Exchange - SEATS
FAQ
What is the Zoono share price?
As of Today at 07:25 UTC, shares in Zoono are trading at AU$0.21. This share price information is delayed by 15 minutes.
How has the Zoono share price performed this year?
Shares in Zoono last closed at AU$0.21 and the price had moved by -70% over the past 365 days. In terms of relative price strength the Zoono share price has underperformed the ASX All Ordinaries Index by -70.47% over the past year.
What are the analyst and broker recommendations for Zoono?
There is no consensus recommendation for this security.
What is the Zoono dividend yield?
Zoono does not currently pay a dividend.
Does Zoono pay a dividend?
Zoono does not currently pay a dividend.
When does Zoono next pay dividends?
Zoono does not currently pay a dividend.
How do I buy Zoono shares?
To buy shares in Zoono you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Zoono?
As of the previous close price of AU$0.21, shares in Zoono had a market capitalisation of AU$34.72m.
Where are Zoono shares listed?
Here are the trading details for Zoono:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: ZNO
What kind of share is Zoono?
Based on an overall assessment of its quality, value and momentum Zoono is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Zoono share price forecast for 2022?
We could not find analyst target price data for this security.
What is the trend in the Zoono share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zoono. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -45.8%.
As of the last closing price of AU$0.21, shares in Zoono were trading -42.91% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Zoono PE Ratio?
The Zoono PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.21.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Zoono?
Zoono's management team is headed by:
- Paul Ravlich - CFO
- Paul Hyslop - MDR
- Elissa Hansen - DRC
- Don Clarke - NID